327 related articles for article (PubMed ID: 9177226)
21. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).
St Croix B; Sheehan C; Rak JW; Flørenes VA; Slingerland JM; Kerbel RS
J Cell Biol; 1998 Jul; 142(2):557-71. PubMed ID: 9679152
[TBL] [Abstract][Full Text] [Related]
22. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.
Sgambato A; Cittadini A; Faraglia B; Weinstein IB
J Cell Physiol; 2000 Apr; 183(1):18-27. PubMed ID: 10699962
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
[TBL] [Abstract][Full Text] [Related]
24. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
Sweeney KJ; Swarbrick A; Sutherland RL; Musgrove EA
Oncogene; 1998 Jun; 16(22):2865-78. PubMed ID: 9671407
[TBL] [Abstract][Full Text] [Related]
25. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
26. Cyclin A correlates with carcinogenesis and metastasis, and p27(kip1) correlates with lymphatic invasion, in colorectal neoplasms.
Li JQ; Miki H; Wu F; Saoo K; Nishioka M; Ohmori M; Imaida K
Hum Pathol; 2002 Oct; 33(10):1006-15. PubMed ID: 12395374
[TBL] [Abstract][Full Text] [Related]
27. p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma.
Fornaro M; Tallini G; Zheng DQ; Flanagan WM; Manzotti M; Languino LR
J Clin Invest; 1999 Feb; 103(3):321-9. PubMed ID: 9927492
[TBL] [Abstract][Full Text] [Related]
28. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
[TBL] [Abstract][Full Text] [Related]
29. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
Mann DJ; Higgins T; Jones NC; Rozengurt E
Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
[TBL] [Abstract][Full Text] [Related]
30. Expression of cyclin-dependent kinase inhibitor p27(Kip1) in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1.
Gloghini A; Gaidano G; Larocca LM; Pierconti F; Cingolani A; Dal Maso L; Capello D; Franceschi S; Tirelli U; Libra M; Niu H; Dalla-Favera R; Carbone A
Am J Pathol; 2002 Jul; 161(1):163-71. PubMed ID: 12107101
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
32. Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma.
Shapira M; Ben-Izhak O; Bishara B; Futerman B; Minkov I; Krausz MM; Pagano M; Hershko DD
Cancer; 2004 Apr; 100(8):1615-21. PubMed ID: 15073847
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of cyclin E and cyclin-dependent kinase inhibitor (p27Kip1): effect on cell cycle regulation in HeLa cells.
Kwon TK; Nordin AA
Biochem Biophys Res Commun; 1997 Sep; 238(2):534-8. PubMed ID: 9299546
[TBL] [Abstract][Full Text] [Related]
34. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
35. Cell type-specific induction of cyclin D and cyclin-dependent kinase inhibitor p27(kip1) expression by estrogen in rat endometrium.
Zhuang YH; Sarca D; Weisz A; Altucci L; Cicatiello L; Rollerova E; Tuohimaa P; Ylikomi T
J Steroid Biochem Mol Biol; 2001 Aug; 78(2):193-9. PubMed ID: 11566444
[TBL] [Abstract][Full Text] [Related]
36. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
[TBL] [Abstract][Full Text] [Related]
37. Expression of P27(KIP1) is prognostic and independent of MYCN amplification in human neuroblastoma.
Bergmann E; Wanzel M; Weber A; Shin I; Christiansen H; Eilers M
Int J Cancer; 2001 May; 95(3):176-83. PubMed ID: 11307151
[TBL] [Abstract][Full Text] [Related]
38. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.
Sánchez-Beato M; Camacho FI; Martínez-Montero JC; Sáez AI; Villuendas R; Sánchez-Verde L; García JF; Piris MA
Blood; 1999 Jul; 94(2):765-72. PubMed ID: 10397744
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
40. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
